1351069-92-5

Upstream product

• 872025-84-8 (S_P)-2'-O-(tert-butyldimethylsilyl)-8-(2-furyl)adenosine-3',5'-cyclic N-benzylphosphoramidate 
• 16114-05-9 N,N'-bis(dimethylaminomethylene)hydrazine 
• 16227-06-8 {N'-[(dimethylamino)methylene]-N,N-dimethylhydrazonoformamide dihydrochloride} 

Downstream Products

• 1351184-81-0 C₂₁H₂₀N₅O₆PS 
• 1351070-06-8 (R(P))-N₆-benzyl-8-(2-furyl)adenosine cyclic 3',5'-phosphorothioic acid tri-n-butylammonium salt 
• 1351070-11-5 (R(P))-N₆-benzyl-8-(2-furyl)adenosine cyclic 3',5'-phosphorothioic acid sodium salt 
• 1351069-94-7 (S(P))-2'O-(tert-butyldimethylsilyl)-8-(2-furyl)-N₆,N₆-dimethyladenosine cyclic 3',5'-N-benzylphosphoramidate 
• 1351069-96-9 (S(P))-2'O-(tert-butyldimethylsilyl)-8-(2-furyl)-N₆-methyladenosine cyclic 3',5'-N-benzylphosphoramidate 
• 1351069-97-0 (S(P))-N₆-benzyl-2'O-(tert-butyldimethylsilyl)-8-(2-furyl)adenosine cyclic 3',5'-N-benzylphosphoramidate 

Relevant academic research and scientific papers

Stereoselective synthesis of (RP)-8-substituted-N 6-acylated and N6-alkylated adenosine-3′,5′- cyclic phosphorothioic acids as cAMP antagonists

N6-Monoalkylated, N6-dialkylated and N 6-acylated (RP)-adenosine 3′,5′-cyclic phosphorothioic acids have been prepared by stereoselective syntheses from cAMP for a study of protein kinase A antagonist activity.